About: NanOlogy
Profile:
Posts by NanOlogy:
- DFB Soria Completes a Phase 2 Clinical Trial of Submicron Particle Paclitaxel Anhydrous Ointment for Actinic Keratosis (September 18, 2018 - NanOlogy Press Release, Soria)
- Drug Development: Targeted Delivery of Submicron Particle Cancer Chemotherapy: Helping Shift the Immunotherapy Paradigm (August 29, 2018 - NanOlogy in the News)
- NanOlogy™ Adds Clinical Trial Sites for Phase 2 Clinical Trials of NanoPac® in Pancreatic Cancer and Pancreatic Mucinous Cysts (August 8, 2018 - NanOlogy Press Release)
- ASCO 2018 Poster: NanoPac Inhalation Treatment of NSCLC in a Nude Rat Orthotopic Lung Cancer Model (June 4, 2018 - Publications)
- Drug Delivery: NanOlogy Touts Preclinical Data for Inhaled NanoPac Cancer Drug (May 30, 2018 - NanOlogy in the News)
- NanOlogy to Unveil Positive Preclinical Data for Inhaled NanoPac® in Treatment of Lung Cancer at 2018 ASCO Annual Meeting (May 29, 2018 - NanOlogy Press Release)
- Boston Business Journal: NanOlogy Completes Dose Escalation Portion of Phase 2 Clinical Trial of NanoPac for Treatment of Prostate Cancer (May 3, 2018 - NanOlogy in the News)
- NanOlogy Completes Dose Escalation Portion of Phase 2 Clinical Trial of NanoPac® for Treatment of Prostate Cancer (April 30, 2018 - NanOlogy Press Release)
- NanOlogy to Present Abstract on Preclinical Study of Nebulized NanoPac for Lung Cancer at 2018 ASCO Annual Meeting (April 25, 2018 - NanOlogy Press Release)
- BioCentury: Tiny Taxanes – How Nanology’s Particle Production Technology Created Submicron Chemotherapy (April 9, 2018 - NanOlogy in the News)
- Drug Delivery: NanOlogy looks to transform chemotherapy with localized delivery platform (March 5, 2018 - NanOlogy in the News)
- Drug Development: NanOlogy Submicron Particle Platform Transforms Systemic Chemotherapy Into Local Delivery (February 28, 2018 - NanOlogy in the News)
- DermWire: NanOlogy Enrolls First Patient in Clinical Trial for Cutaneous Metastases (February 14, 2018 - NanOlogy in the News)
- NanOlogy Announces First Patient Enrolled in a Phase 2 Clinical Trial for Cutaneous Metastases and DFB Soria Provides an Update on AK Trial (February 14, 2018 - NanOlogy Press Release, Soria)
- Houston Business Journal: NanOlogy to Update Clinical Program at BIO CEO Conference (February 5, 2018 - NanOlogy in the News)
- NanOlogy to Update Clinical Program Transforming Treatment of Cancer at BIO CEO and Investor Conference (February 5, 2018 - NanOlogy Press Release, Soria)
- NanOlogy General Presentation (Jan 2018) (January 9, 2018 - Publications)
- PharmaVOICE: Next-Generation Nanomedicines (January 3, 2018 - NanOlogy in the News)
